A phase III study of standard fractionation radiotherapy with concurrent high-dose cisplatin versus accelerated fractionation radiotherapy (RT) with panitumumab in patients with locally advanced stage III and IV squamous cell carcinoma of the head and neck (SCCHN) (NCIC Clinical Trials Group HN.6).

Abstract

TPS5600

Waldron JN; Parulekar W; O'Sullivan B; Chen BE; Montenegro A; Nabid A; Winquist E; Wright JR; Hay J; Ringash J

Journal of Clinical Oncology, Vol. 30, No. 15_suppl, pp. tps5600–tps5600

American Society of Clinical Oncology (ASCO)

May 20, 2012

10.1200/jco.2012.30.15_suppl.tps5600

0732-183X

James Wright